AMCP submits comments on Draft CY2018 Medicare Part B Physician Fee Schedule urging CMS to critically evaluate coding & reimbursement options under Part B to ensure patient access and affordability of biologics and biosimilars, require documentation of P
AMCP submits comments on Draft CY2018 Medicare Part B Physician Fee Schedule urging CMS to critically evaluate coding & reimbursement options under Part B to ensure patient access and affordability of biologics and biosimilars, require documentation of P